MarketBeat Instant News Alerts

2 hours ago

SOPHiA GENETICS (NASDAQ:SOPH) CEO Ross Muken Sells 9,838 Shares

MarketBeat

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) CEO Ross Muken sold 9,838 shares of SOPHiA GENETICS stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $5.22, for a total value of $51,354.36. Following the completion of the sale, the chief executive officer owned 670,651 shares in the company, valued at approximately $3,500,798.22. This trade represents a 1.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

NASDAQ:SOPH

2 hours ago

Jurgi Camblong Sells 22,486 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock

MarketBeat

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) Chairman Jurgi Camblong sold 22,486 shares of the firm's stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $5.25, for a total value of $118,051.50. Following the transaction, the chairman owned 3,558,807 shares of the company's stock, valued at $18,683,736.75. This trade represents a 0.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

NASDAQ:SOPH

2 hours ago

Crinetics Pharmaceuticals (NASDAQ:CRNX) Director Coelho Rogerio Vivaldi Sells 3,000 Shares of Stock

MarketBeat

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Get Free Report) Director Coelho Rogerio Vivaldi sold 3,000 shares of the firm's stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $40.00, for a total value of $120,000.00. Following the sale, the director directly owned 19,225 shares in the company, valued at $769,000. The trade was a 13.50% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NASDAQ:CRNX

2 hours ago

Regeneron Pharmaceuticals (NASDAQ:REGN) Director Sells 200 Shares

MarketBeat

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Get Free Report) Director Arthur Ryan sold 200 shares of the business's stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $650.15, for a total value of $130,030.00. Following the completion of the transaction, the director directly owned 17,303 shares of the company's stock, valued at $11,249,545.45. The trade was a 1.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NASDAQ:REGN

2 hours ago

Roblox (NYSE:RBLX) Insider Sells $258,718.08 in Stock

MarketBeat

Roblox Corporation (NYSE:RBLX - Get Free Report) insider Mark Reinstra sold 4,512 shares of the company's stock in a transaction on Monday, July 6th. The stock was sold at an average price of $57.34, for a total value of $258,718.08. Following the transaction, the insider owned 422,248 shares of the company's stock, valued at approximately $24,211,700.32. The trade was a 1.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE:RBLX

2 hours ago

Oluyemi Okupe Sells 7,163 Shares of Hims & Hers Health (NYSE:HIMS) Stock

MarketBeat

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 7,163 shares of Hims & Hers Health stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $36.49, for a total value of $261,377.87. Following the completion of the sale, the chief financial officer owned 284,321 shares of the company's stock, valued at $10,374,873.29. The trade was a 2.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE:HIMS

World Investment Advisors Raises Stake in Intel Corporation $INTC

NVIDIA (NASDAQ:NVDA) Stock Rating Lowered by Wall Street Zen

Lam Research (NASDAQ:LRCX) Shares Down 10.2% - Here's What Happened

Advanced Micro Devices, Inc. $AMD Shares Sold by Canvas Wealth Advisors LLC

NVIDIA Corporation $NVDA Shares Purchased by TRU Independence Asset Management 2 LLC

AST SpaceMobile (NASDAQ:ASTS) Shares Down 5.3% - Here's Why

International Business Machines (NYSE:IBM) Stock Price Up 3.5% Following Analyst Upgrade

All MarketBeat Instant News Alerts

Sort By

Time Frame

Alert Type

Keywords

2 hours ago

World Kinect (NYSE:WKC) Chairman Michael Kasbar Sells 10,000 Shares of Stock

MarketBeat

NYSE:WKC

2 hours ago

Ourania Tatsis Sells 1,500 Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) Stock

NASDAQ:IPGP

Alert Categories

All Alerts

Page 1 of 199

1 2 3 4 5 6 7 Earlier › Earliest »

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MarketBeat Instant News Alerts

SOPHiA GENETICS (NASDAQ:SOPH) CEO Ross Muken Sells 9,838 Shares

Jurgi Camblong Sells 22,486 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock

Crinetics Pharmaceuticals (NASDAQ:CRNX) Director Coelho Rogerio Vivaldi Sells 3,000 Shares of Stock

Regeneron Pharmaceuticals (NASDAQ:REGN) Director Sells 200 Shares

Roblox (NYSE:RBLX) Insider Sells $258,718.08 in Stock

Oluyemi Okupe Sells 7,163 Shares of Hims & Hers Health (NYSE:HIMS) Stock

Trending News

All MarketBeat Instant News Alerts

World Kinect (NYSE:WKC) Chairman Michael Kasbar Sells 10,000 Shares of Stock

Ourania Tatsis Sells 1,500 Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) Stock

Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Sells $799,779.00 in Stock

Twilio (NYSE:TWLO) CFO Aidan Viggiano Sells 8,528 Shares

De Lima Filho Pedro Batista Sells 255,800 Shares of Brazilian Electric Power (NYSE:AXIA) Stock

DoorDash (NASDAQ:DASH) Director Sells 23,125 Shares of Stock

Datadog (NASDAQ:DDOG) Director Sells $5,224,400.00 in Stock

Altria Group (NYSE:MO) Shares Up 1.5% After Analyst Upgrade

Visa (NYSE:V) Shares Down 1.4% on Insider Selling

Ondas (NASDAQ:ONDS) Shares Down 6% Following Analyst Downgrade

Eli Lilly and Company (NYSE:LLY) Trading 2.8% Higher After Analyst Upgrade

Nebius Group (NASDAQ:NBIS) Trading Down 8.4% Following Insider Selling

International Business Machines (NYSE:IBM) Trading Up 2.2% After Analyst Upgrade

Meta Platforms (NASDAQ:META) Stock Price Up 2.5% Following Analyst Upgrade

Micron Technology (NASDAQ:MU) Trading Down 4.7% on Insider Selling

Stock Traders Buy High Volume of Call Options on CSX (NASDAQ:CSX)

SM Energy (NYSE:SM) Trading 6.9% Higher - What's Next?

Kosmos Energy (NYSE:KOS) Shares Up 7.2% - What's Next?

Patterson-UTI Energy (NASDAQ:PTEN) Shares Up 7.5% - What's Next?

Fluence Energy (NASDAQ:FLNC) Shares Down 10.2% - Here's What Happened

Life Time Group (NYSE:LTH) Reaches New 12-Month High - Still a Buy?

SailPoint (NASDAQ:SAIL) Trading Up 6.5% - What's Next?

nLight (NASDAQ:LASR) Trading Down 9.2% - Should You Sell?

IPG Photonics (NASDAQ:IPGP) Trading Down 9.3% - Time to Sell?

Featured Articles and Offers

Alert Categories

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools